Medindia

X

Pfizer Reports Second-Quarter 2010 Results

Tuesday, August 3, 2010 Corporate News J E 4
Advertisement

Full-Year 2012 Targets

($ billions, except per-share amounts)

Net Income(b)

Diluted EPS(b)

Income/(Expense)

Adjusted Income/Diluted EPS(1) Targets

~$18.3 - $19.1

~$2.25 - $2.35

Purchase Accounting Impacts of Transactions Completed as of 7/4/10

(3.8)

(0.47)

Acquisition-Related Costs

(1.2 – 1.6)

(0.15 – 0.20)

Reported Net Income Attributable to Pfizer Inc./Diluted EPS Targets

~$12.9 - $14.1

~$1.58 - $1.73

(a) The current exchange rates assumed in connection with the 2012 financial targets are the mid-July 2010 exchange rates.

(b)Given the longer-term nature of these targets, they are subject to greater variability and less certainty as a result of potential material impacts related to foreign exchange fluctuations, macroeconomic activity including inflation, and industry-specific challenges including changes to government healthcare policy, among others. 

Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
West Announces Second Quarter 2010 Results
S
Advocate Health Care Commences Implementation of C...